70 related articles for article (PubMed ID: 396148)
21. Mutagenicity of metabolically activated benzo[a]anthracene 3,4-dihydrodiol: evidence for bay region activation of carcinogenic polycyclic hydrocarbons.
Wood AW; Levin W; Lu AY; Ryan D; West SB; Lehr RE; Schaefer-Ridder M; Jerina DM; Conney AH
Biochem Biophys Res Commun; 1976 Sep; 72(2):680-6. PubMed ID: 791280
[No Abstract] [Full Text] [Related]
22. Synthesis and bacterial mutagenicity of the cyclopenta oxides of the four cyclopenta-fused isomers of benzanthracene.
Bartczak AW; Sangaiah R; Ball LM; Warren SH; Gold A
Mutagenesis; 1987 Mar; 2(2):101-5. PubMed ID: 3331698
[TBL] [Abstract][Full Text] [Related]
23. Conjugation of 7-hydroxymethyl-12-methylbenz[a]anthracene (7-HMBA) with glutathione via a sulphate ester in hepatic cytosol.
Watabe T; Ishizuka T; Ozawa N; Isobe M
Biochem Pharmacol; 1982 Aug; 31(15):2542-4. PubMed ID: 6812593
[No Abstract] [Full Text] [Related]
24. Synthesis and mutagenicity of 5,11-dimethylchrysene and some methyl-oxidized derivatives of 5-methylchrysene.
Amin S; Hecht SS; LaVoie E; Hoffmann D
J Med Chem; 1979 Nov; 22(11):1336-40. PubMed ID: 392098
[TBL] [Abstract][Full Text] [Related]
25. Metabolic activation of dibenzo(a,h)anthracene and its dihydrodiols to bacterial mutagens.
Wood AW; Levin W; Thomas PE; Ryan D; Karle JM; Yagi H; Jerina DM; Conney AH
Cancer Res; 1978 Jul; 38(7):1967-73. PubMed ID: 350381
[No Abstract] [Full Text] [Related]
26. The preparation of 7-hydroxymethylbenz(a)anthracene 5,6-oxide and its metabolism by rat-liver preparations.
Sims P
Xenobiotica; 1972 Sep; 2(5):469-77. PubMed ID: 4649043
[No Abstract] [Full Text] [Related]
27. Non-enzymatic ATP-mediated binding of hydroxymethyl derivatives of aromatic hydrocarbons to DNA.
Rogan EG; Roth RW; Katomski-Beck PA; Laubscher JR; Cavalieri EL
Chem Biol Interact; 1980 Jul; 31(1):51-63. PubMed ID: 6156020
[TBL] [Abstract][Full Text] [Related]
28. Strong influence of the exposure medium on mutagenicity in the Ames test: 7-methylbenz[a]anthracene-5,6-oxide.
Glatt H; Martiné U; Baidossi W; Blum J
Mutagenesis; 1991 Nov; 6(6):537-40. PubMed ID: 1800902
[TBL] [Abstract][Full Text] [Related]
29. Binding of the carcinogens 5-fluoro-7-hydroxymethyl-12-methylbenz(a)anthracene and its acetate ester to DNA in vitro.
Chien MT; Flesher JW
Life Sci; 1981 Mar; 28(10):1175-81. PubMed ID: 7231045
[No Abstract] [Full Text] [Related]
30. Evaluation of the mutagenicity of compounds of known carcinogenicity, belonging to the benz[a]anthracene, chrysene, and cyclopenta[a]phenanthrene series, using Ames's test.
Coombs MM; Dixon C; Kissonerghis AM
Cancer Res; 1976 Dec; 36(12):4525-9. PubMed ID: 793712
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of metabolic activation of 7,12-dimethylbenz(a)anthracene in vitro by aroclor 1254-induced rat liver S-9 fraction.
Bigger CA; Tomaszewski JE; Andrews AW; Dipple A
Cancer Res; 1980 Mar; 40(3):655-61. PubMed ID: 6781743
[TBL] [Abstract][Full Text] [Related]
32. Comparison of metabolism-mediated binding to DNA of 7-hydroxymethyl-12-methylbenz(a)anthracene and 7, 12-dimethylbenz(a)anthracene.
Dipple A; Tomaszewski JE; Moschel RC; Bigger CA; Nebzydoski JA; Egan M
Cancer Res; 1979 Apr; 39(4):1154-8. PubMed ID: 105803
[TBL] [Abstract][Full Text] [Related]
33. Frameshift mutagenicity of dinitrobenzene derivatives on Salmonella typhimurium TA98 and Tm elevation of calf thymus DNA by dinitrobenzene derivatives.
Furukawa H; Kawai N; Kawai K
Nucleic Acids Symp Ser; 1985; (16):5-8. PubMed ID: 3911171
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of a diol-epoxide and a K-region epoxide with high efficiency by glutathione transferase X.
Glatt H; Friedberg T; Grover PL; Sims P; Oesch F
Cancer Res; 1983 Dec; 43(12 Pt 1):5713-7. PubMed ID: 6357430
[TBL] [Abstract][Full Text] [Related]
35. Anthracene-9,10-diones as potential anticancer agents: bacterial mutation studies of amido-substituted derivatives reveal an unexpected lack of mutagenicity.
Venitt S; Crofton-Sleigh C; Agbandje M; Jenkins TC; Neidle S
J Med Chem; 1998 Sep; 41(19):3748-52. PubMed ID: 9733500
[TBL] [Abstract][Full Text] [Related]
36. The formation and metabolism of N-hydroxymethyl compounds--IX. N-(acetoxymethyl)-4-chlorobenzamide: an electrophile but not a mutagen in Salmonella typhimurium.
Overton M; Threadgill MD; Chipman JK; Gescher A; Hickman JA
Biochem Pharmacol; 1986 Dec; 35(23):4161-5. PubMed ID: 3539117
[TBL] [Abstract][Full Text] [Related]
37. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
38. Salmonella mutagenicity of musk ambrette depends on both microsomal and bacterial enzyme activity.
Mersch-Sundermann V; Emig M
Anticancer Res; 1998; 18(2A):829-31. PubMed ID: 9615727
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, absolute configuration, and bacterial mutagenicity of the 8 stereoisomeric vicinal diol epoxides at the terminal benzo ring of carcinogenic dibenz[a,h]anthracene.
Frank H; Funk M; Oesch F; Platt KL
Chem Res Toxicol; 2011 Dec; 24(12):2258-68. PubMed ID: 22087540
[TBL] [Abstract][Full Text] [Related]
40. The 7-methylbenz(a)anthracene deoxyribonucleoside products isolated from DNA after metabolism of the carcinogen by rat liver microsomes in the presence of DNA.
Thompson MH; Osborne MR; King HW; Brookes P
Chem Biol Interact; 1976 Jul; 14(1-2):13-9. PubMed ID: 954132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
